Millennium Management
FRTX

Millennium Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Millennium Management’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20,912
Closed -$14K – 6919
2023
Q1 		$14K Sell
20,912
-312
-1% -$521 ﹤0.01% 5959
2022
Q4 		$31K Sell
21,224
-7,506
-26% -$13.3K ﹤0.01% 5931
2022
Q3 		$51K Buy
28,730
+17,603
+158% +$51K ﹤0.01% 6182
2022
Q2 		$63K Buy
+11,127
New +$101K ﹤0.01% 6109
2022
Q1 		– Sell
-1,061
Closed -$11K – 7743
2021
Q4 		$11K Buy
+1,061
New +$19.1K ﹤0.01% 6648
2021
Q3 		– Sell
-403
Closed -$17K – 7410
2021
Q2 		$17K Buy
+403
New +$16.6K ﹤0.01% 6438
2021
Q1 		– Sell
-7,261
Closed -$255K – 6627
2020
Q4 		$255K Buy
+7,261
New +$228K ﹤0.01% 4665
2020
Q3 		– Sell
-3,035
Closed -$137K – 4922
2020
Q2 		$137K Buy
+3,035
New +$162K ﹤0.01% 3931
2018
Q2 		– Sell
-39
Closed -$18K – 4285
2018
Q1 		$18K Sell
39
-405
-91% -$201K ﹤0.01% 3570
2017
Q4 		$256K Buy
+444
New +$293K ﹤0.01% 3416
2015
Q3 		– Sell
-4
Closed -$9K – 3808
2015
Q2 		$9K Sell
4
-4
-50% -$12.5K ﹤0.01% 3253
2015
Q1 		$25K Sell
8
-42
-84% -$134K ﹤0.01% 3494
2014
Q4 		$166K Buy
50
+11
+28% +$39K ﹤0.01% 3685
2014
Q3 		$138K Buy
39
+8
+26% +$31.1K ﹤0.01% 3500
2014
Q2 		$118K Buy
+31
New +$117K ﹤0.01% 3238
2013
Q4 		– Sell
-4
Closed -$18K – 3869
2013
Q3 		$18K Sell
4
-15
-79% -$113K ﹤0.01% 3248
2013
Q2 		$192K Buy
+19
New +$210K ﹤0.01% 2767

Other funds holding FRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Millennium Management's FRTX Position: Q2 2023 in Review

Millennium Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2023, closing a stake of 20,912 shares — an estimated $14K sold.

Millennium Management first reported a position in FRTX in Q2 2013 and held it in 17 quarters. The position peaked at $256K in Q4 2017. 15 funds tracked by Wall St. Rank hold FRTX as of Q2 2023.

  • Millennium Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Millennium Management sold 20,912 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $14K.
  • Millennium Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 17 quarters.
  • Millennium Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $256K in Q4 2017.
  • 15 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.